Inappropriate dose of direct oral anticoagulants therapy in patients with non-valvular atrial fibrillation

被引：0
|
作者：
Ito, M. [1 ]
Kaikita, K. [1 ]
Sueta, D. [1 ]
Ishii, M. [1 ]
Oimatsu, Y. [1 ]
Mitsuse, T. [1 ]
Arima, Y. [1 ]
Iwashita, S. [1 ]
Takahashi, A. [1 ]
Kanazawa, H. [1 ]
Kaneko, S. [1 ]
Kanemaru, Y. [1 ]
Kiyama, T. [1 ]
Yamabe, H. [1 ]
Tsujita, K. [1 ]
机构：
[1] Kumamoto Univ, Kumamoto Univ Hosp, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2504
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [41] Renal outcomes in Asian patients receiving oral anticoagulants for non-valvular atrial fibrillation
    Shahzada, Tayyab Salim
    Guo, Cosmos L.
    Lee, Alex P. W.
    HONG KONG MEDICAL JOURNAL, 2022, 28 (01) : 24 - 32
  • [42] Prescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
    Generalova, Daria
    Cunningham, Scott
    Leslie, Stephen J.
    Rushworth, Gordon F.
    Mciver, Laura
    Stewart, Derek
    PHARMACY PRACTICE-GRANADA, 2020, 18 (02): : 1 - 6
  • [43] Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
    Ki Won Hwang
    Jin Hee Choi
    Soo Yong Lee
    Sang Hyun Lee
    Min Ku Chon
    Jungkuk Lee
    Hasung Kim
    Yong-Giun Kim
    Hyung Oh Choi
    Jeong Su Kim
    Yong-Hyun Park
    June Hong Kim
    Kook Jin Chun
    Gi-Byoung Nam
    Kee-Joon Choi
    BMC Cardiovascular Disorders, 23
  • [44] Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
    Yamato, Hiroshi
    Abe, Koichiro
    Osumi, Shun
    Yanagisawa, Daisuke
    Kodashima, Shinya
    Asaoka, Yoshinari
    Konno, Kumiko
    Kozuma, Ken
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [45] Comparative Outcomes of Direct Oral Anticoagulants versus Warfarin in Morbidly Obese Patients With Non-valvular Atrial Fibrillation
    Barakat, Amr F.
    Jain, Sandeep
    Masri, Ahmad
    Senussi, Mourad
    Wang, Yisi
    Bhonsale, Aditya
    Saba, Samir
    Mulukutla, Suresh R.
    CIRCULATION, 2019, 140
  • [46] Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants
    Chang, Kuo-Hsuan
    Chen, Chiung-Mei
    Wang, Chun-Li
    Tu, Hui-Tzu
    Huang, Yu-Tung
    Wu, Hsiu-Chuan
    Chang, Chien-Hung
    Chang, Shang-Hung
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [47] Real-world persistence with direct oral anticoagulants (DOACs) in naive patients with non-valvular atrial fibrillation
    Ferroni, Eliana
    Gennaro, Nicola
    Costa, Giorgio
    Fedeli, Ugo
    Denas, Gentian
    Pengo, Vittorio
    Corti, Maria Chiara
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 288 : 72 - 75
  • [48] Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation
    Yanagisawa, Daisuke
    Abe, Koichiro
    Amano, Hirohito
    Komatsuda, Shogo
    Honda, Taku
    Manabe, Daisuke
    Yamamoto, Hirosada
    Kozuma, Ken
    Kodashima, Shinya
    Asaoka, Yoshinari
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    PLOS ONE, 2021, 16 (11):
  • [49] Impact of Renal Function on Bleeding Risk in Patients With Non-Valvular Atrial Fibrillation Treated With Direct Oral Anticoagulants
    Kobayashi, Tomoaki
    Sotomi, Yohei
    Hirata, Akio
    Hirayama, Atsushi
    Higuchi, Yoshiharu
    CIRCULATION, 2019, 140
  • [50] Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation
    Saliba, Layla
    Mondoly, Pierre
    Duparc, Alexandre
    Bura-Riviere, Alessandra
    Maury, Philippe
    Calmels, Violaine
    Sallerin, Brigitte
    Pathak, Atul
    Montastruc, Jean-Louis
    Bagheri, Haleh
    THERAPIE, 2015, 70 (06): : 485 - 492
12345